.Innovent Biologics has actually created the situation that its checkpoint inhibitor-cytokine combin...
.A phase 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate...
.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has sig...
.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, mentioning phase 3 growt...
.Though Alkeus Pharmaceuticals' dental eye disease asset failed to substantially reduce geographical...
.Along with a triad of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to sk...
.Invulnerable gate inhibitors are the superheroes of cancer cells therapy. Medications like Bristol ...
.Welcome to today's Chutes & Ladders, our summary of considerable management hirings, firings as ...
.Regeneron is back along with long-term consequence for its own LAG-3 prevention and PD-1 prevention...
.AstraZeneca has discussed a very early examine the efficiency of its in-house antibody-drug conjuga...